1. Home
  2. LGVN vs CLEU Comparison

LGVN vs CLEU Comparison

Compare LGVN & CLEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • CLEU
  • Stock Information
  • Founded
  • LGVN 2014
  • CLEU 2011
  • Country
  • LGVN United States
  • CLEU China
  • Employees
  • LGVN N/A
  • CLEU N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • CLEU Other Consumer Services
  • Sector
  • LGVN Health Care
  • CLEU Real Estate
  • Exchange
  • LGVN Nasdaq
  • CLEU Nasdaq
  • Market Cap
  • LGVN 25.2M
  • CLEU 29.3M
  • IPO Year
  • LGVN 2021
  • CLEU 2020
  • Fundamental
  • Price
  • LGVN $1.56
  • CLEU $0.09
  • Analyst Decision
  • LGVN Strong Buy
  • CLEU
  • Analyst Count
  • LGVN 3
  • CLEU 0
  • Target Price
  • LGVN $8.67
  • CLEU N/A
  • AVG Volume (30 Days)
  • LGVN 161.2K
  • CLEU 51.3M
  • Earning Date
  • LGVN 02-28-2025
  • CLEU 10-11-2024
  • Dividend Yield
  • LGVN N/A
  • CLEU N/A
  • EPS Growth
  • LGVN N/A
  • CLEU N/A
  • EPS
  • LGVN N/A
  • CLEU N/A
  • Revenue
  • LGVN $1,852,000.00
  • CLEU $2,413,409.00
  • Revenue This Year
  • LGVN $208.32
  • CLEU N/A
  • Revenue Next Year
  • LGVN $43.96
  • CLEU N/A
  • P/E Ratio
  • LGVN N/A
  • CLEU N/A
  • Revenue Growth
  • LGVN 141.46
  • CLEU N/A
  • 52 Week Low
  • LGVN $0.77
  • CLEU $0.09
  • 52 Week High
  • LGVN $6.40
  • CLEU $7.90
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 45.58
  • CLEU 31.94
  • Support Level
  • LGVN $1.53
  • CLEU $0.09
  • Resistance Level
  • LGVN $1.71
  • CLEU $0.11
  • Average True Range (ATR)
  • LGVN 0.13
  • CLEU 0.02
  • MACD
  • LGVN 0.02
  • CLEU -0.10
  • Stochastic Oscillator
  • LGVN 38.30
  • CLEU 1.10

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About CLEU China Liberal Education Holdings Limited

China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.

Share on Social Networks: